Laurel Anderson Cowell, MD
Allergy · Portland, ORNPI 1356346217
Payments from drug & device makers
Across 20 payments — averaging $56.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jubilant Hollisterstier LLC$574
- Genentech USA, Inc.$141
- Takeda Pharmaceuticals U.S.A., Inc.$120
- Regeneron Healthcare Solutions, Inc.$64
- CSL Behring$31
- Sanofi$30
- plus $162 from 7 others
What the payments were for
- Consulting fees$222%
- Food & beverage$52747%
- Gifts$57451%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jubilant Hollisterstier LLC | 2 | $574 |
| Genentech USA, Inc. | 1 | $141 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $120 |
| Regeneron Healthcare Solutions, Inc. | 2 | $64 |
| CSL Behring | 1 | $31 |
| Sanofi | 2 | $30 |
| Shire North American Group Inc | 1 | $30 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $29 |
| Biocryst US Sales Co., LLC | 1 | $24 |
| Pfizer | 1 | $22 |
| ADMA Biomanufacturing LLC | 1 | $22 |
| AstraZeneca | 1 | $20 |
| Pharming Healthcare, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- STANDARDIZED CAT HAIR$435
- STANDARDIZED MITE, DERMATOPHAGOIDES FARINAE$435
- XOLAIR$141
- Animal Allergens, AP Dog Hair and Dander Canis spp$139
How this compares
Too few allergy providers in Oregonto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 209 | $152,532 |
| Breo ElliptaFluticasone/Vilanterol | 209 | $113,995 |
| NucalaMepolizumab | 13 | $55,657 |
| XolairOmalizumab | 17 | $49,573 |
| Cromolyn Sodium | 13 | $16,989 |
| Arnuity ElliptaFluticasone Furoate | 51 | $13,936 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 19 | $12,043 |
| Qvar RedihalerBeclomethasone Dipropionate | 27 | $10,140 |
| DuleraMometasone/Formoterol | 27 | $8,766 |
| Fluticasone-VilanterolFluticasone/Vilanterol | 20 | $6,702 |
| Epinephrine | 29 | $6,441 |
| Montelukast Sodium | 393 | $4,972 |
| BreynaBudesonide/Formoterol Fumarate | 18 | $4,818 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 112 | $4,344 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 23 | $4,337 |
Paid to pharmacies, not to this prescriber.
Other allergy in Portland
- Edward KerwinMedford$6.8M
- Kevin ParksMedford$243K
- Alice ChouEugene$4K
- Candice RohrEugene$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.